Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar
Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...
Promising Small Biotech Amphastar Sees Actionable Pullback
Small-cap Amphastar Pharmaceuticals is pulling back from recent highs in an orderly fashion, potentially offering a new entry point after beating Q1 views.
Lilly to Divest BAQSIMI to Amphastar
/PRNewswire/ -- In an effort to continue expanding the availability of BAQSIMI® to patients, Eli Lilly and Company (NYSE: LLY) and Amphastar Pharmaceuticals,...
Why Shares of Amphastar Pharmaceuticals Rose Today
The company reported a record revenue year and increased EPS.